Loading drug development pipeline…
Loading drug development pipeline…
Derived
For each drug, the most advanced stage supported by registered interventional trials and jurisdiction-aware approval records. Approval in any ingested jurisdiction outranks trial phase; a drug is counted once, at its highest stage.
Computedci-drug-pipeline-v1Stage rulesApprovals feed →
Funnel
Drugs reach Malignant Testicular Neoplasm through trial conditions or approval indications mapped to it or to one of its descendant entities.
21 drugs · 23 active trials
0 drugs · 0 active trials
no drug at this stage
3 drugs · 2 active trials
Outside the funnel: Phase not stated 5. "Withdrawn" = every approval record for the scope is withdrawn or superseded; "phase not stated" = trials exist but none states a phase.
Data updated 17 hours agoSource updated unknownrecomputed with the intelligence layer
Drugs
Most advanced stage first, then most active trials. Trial counts are interventional studies linking the drug (and, when a cancer is selected, the cancer).
| Drug | Stage | Max phase | Active | Recruiting | Phase 3 | Total trials | Approvals | Jurisdictions | First approval | First trial |
|---|---|---|---|---|---|---|---|---|---|---|
| Palbociclib | Phase 2 | Phase 2 | 0 | 0 | 0 | 1 | 0 | — | — | 2009-10 |
| Romidepsin | Phase 2 | Phase 2 | 0 | 0 | 0 | 1 | 0 | — | — | 2016-10 |
| Sorafenib | Phase 2 | Phase 2 | 0 | 0 | 0 | 1 | 0 | — | — | 2008-09 |
| Tremelimumab | Phase 2 | Phase 2 | 0 | 0 | 0 | 1 | 0 | — | — | Dec 28, 2016 |
| Alisertib | Phase 1 | Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | Apr 16, 2012 |
| Bevacizumab | Phase 1 | Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | 2007-05 |
| Cediranib | Phase 1 | Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | 2007-05 |
| Guadecitabine | Phase 1 | Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | Apr 27, 2015 |
| HDAC Inhibitor REC-2282 | Phase 1 | Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | May 4, 2010 |
| Ibrutinib | Phase 1 | Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | 2014-09 |
| Sunitinib | Phase 1 | Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | 2009-08 |
| Topotecan | Phase 1 | Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | Feb 26, 2007 |
| Carmustine | Phase not stated | N/A | 0 | 0 | 0 | 2 | 0 | — | — | Jun 29, 2006 |
| Chemotherapy | Phase not stated | N/A | 0 | 0 | 0 | 1 | 0 | — | — | 1997-09 |
| O6-Benzylguanine | Phase not stated | N/A | 0 | 0 | 0 | 1 | 0 | — | — | 2015-02 |
| Plerixafor | Phase not stated | N/A | 0 | 0 | 0 | 1 | 0 | — | — | 2011-10 |
| Thiotepa | Phase not stated | N/A | 0 | 0 | 0 | 1 | 0 | — | — | Jun 29, 2006 |
Stages describe registered activity and ingested regulatory records, not efficacy. Only ingested jurisdictions (currently US and Canada) can place a drug at "approved"; trial phases are as registered by sponsors. Nothing here is a treatment recommendation.